Zoetis reported $106.6M in Operating Expenses for its second fiscal quarter of 2020.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Aerie Pharmaceuticals AERI:US $ 60.59M 3.7M
Align Technology ALGN:US $ 55.71M 13.18M
Bayer BAYN:GR 2.08B 1.05B
Bristol Myers Squibb BMY:US $ 918.7M 71.3M
Charles River Laboratories CRL:US $ 60.58M 696.2K
Dentsply International XRAY:US $ 594.9M 404.2M
Eli Lilly And LLY:US $ 4302.6M 33.6M
Endo International Ordinary Shares ENDP:US $ 573.09M 29.12M
Henry Schein HSIC:US $ 1691.83M 563.17M
Horizon Pharma HZNP:US $ 422.45M 19.72M
Idexx Laboratories IDXX:US $ 44.43M 3.77M
Illumina ILMN:US $ 53.7M 13.3M
JAZZ PHA JAZZ:US $ 405.28M 36.47M
Johnson & Johnson JNJ:US $ 16.68B 2.28B
Laboratory Of America LH:US $ 2471.1M 545.3M
Merk MRK:US $ 7743M 405M
Neogen NEOG:US $ 90.43M 1.26M
Pacira Pharmaceuticals PCRX:US $ 8.27M 593.8K
Perrigo Ordinary Shares PRGO:US $ 1329.2M 227.5M
Pfizer PFE:US $ 8360M 920M
Quest Diagnostics DGX:US $ 2068M 524M
Teva Pharmaceutical Industries TEVA:US 8.32B 4.62B
Zoetis ZTS:US $ 106.6M 2.9M